Search Results - "Tabernero, Eva"

Refine Results
  1. 1
  2. 2

    COVID-19 in young and middle-aged adults: predictors of poor outcome and clinical differences by Tabernero, Eva, Ruiz, Luis A., España, Pedro P., Méndez, Raúl, Serrano, Leyre, Santos, Borja, Uranga, Ane, González, Paula, Garcia, Patricia, Torres, Antoni, Menendez, Rosario, Zalacain, Rafael

    Published in Infection (01-02-2022)
    “…Introduction Young and middle-aged adults are the largest group of patients infected with SARS-CoV-2 and some of them develop severe disease. Objective To…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Nontuberculous Mycobacteria Isolates in Respiratory Samples and Mycobacterial Pulmonary Disease in an Area of Northern Spain by Ugedo, Javier, Tabernero, Eva, Altube, Lander, Leal, María Victoria, García, Julia Amaranta

    Published in Open respiratory archives (01-10-2024)
    “…[Display omitted] The epidemiology of nontuberculous mycobacteria (NTM) is not well known. In this study, we aimed to determine the incidence of NTM isolates…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Adjusted D-dimer cutoff levels to rule out pulmonary embolism in patients hospitalized for COPD exacerbation: results from the SLICE trial by Rodríguez, Carmen, Jara-Palomares, Luis, Tabernero, Eva, Tenes, Andrés, González, Sara, Briceño, Winnifer, Lobo, José Luis, Morillo, Raquel, Bikdeli, Behnood, Jiménez, David

    Published in Thrombosis journal (03-03-2022)
    “…For patients with suspected pulmonary embolism (PE), age- or clinically-adjusted D-dimer threshold level can be used to define a negative test that safely…”
    Get full text
    Journal Article
  7. 7

    Changing epidemiology of nontuberculous mycobacterial lung disease over the last two decades in a region of the Basque country by Pedrero, Sandra, Tabernero, Eva, Arana-Arri, Eunate, Urra, Elena, Larrea, Maialen, Zalacain, Rafael

    Published in ERJ open research (01-10-2019)
    “…Recent studies suggest an increasing prevalence of nontuberculous mycobacteria (NTM) lung disease. The aim of the present study was to describe incidence rates…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    A Computer Application to Predict Adverse Events in the Short-Term Evolution of Patients With Exacerbation of Chronic Obstructive Pulmonary Disease by Arostegui, Inmaculada, Legarreta, María José, Barrio, Irantzu, Esteban, Cristobal, Garcia-Gutierrez, Susana, Aguirre, Urko, Quintana, José María

    Published in JMIR medical informatics (17-04-2019)
    “…Chronic obstructive pulmonary disease (COPD) is a common chronic disease. Exacerbations of COPD (eCOPD) contribute to the worsening of the disease and the…”
    Get full text
    Journal Article
  19. 19

    Predictive score for mortality in patients with COPD exacerbations attending hospital emergency departments by Quintana, José M, Esteban, Cristóbal, Unzurrunzaga, Anette, Garcia-Gutierrez, Susana, Gonzalez, Nerea, Barrio, Irantzu, Arostegui, Inmaculada, Lafuente, Iratxe, Bare, Marisa, Fernandez-de-Larrea, Nerea, Vidal, Silvia

    Published in BMC medicine (23-04-2014)
    “…Limited information is available about predictors of short-term outcomes in patients with exacerbation of chronic obstructive pulmonary disease (eCOPD)…”
    Get full text
    Journal Article
  20. 20

    Obtaining patient phenotypes in SARS-CoV-2 pneumonia, and their association with clinical severity and mortality by García-García, Fernando, Lee, Dae-Jin, Nieves-Ermecheo, Mónica, Bronte, Olaia, España, Pedro Pablo, Quintana, José María, Menéndez, Rosario, Torres, Antoni, Ruiz Iturriaga, Luis Alberto, Urrutia, Isabel

    Published in Pneumonia (25-06-2024)
    “…There exists consistent empirical evidence in the literature pointing out ample heterogeneity in terms of the clinical evolution of patients with COVID-19. The…”
    Get full text
    Journal Article